Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

DIVI'S LABORATORIES LTD. - 532488 - Closure of Trading Window

 Pursuant to the Company's Code of Conduct for Prevention of Insider Trading (the Code), we hereby inform that the Trading Window for dealing in securities of the Company will remain closed for all Designated Persons and their Immediate Relatives, as well as Insiders covered under the Code, from October 01, 2021 till 48 hours after the declaration of Unaudited Financial Results for the second quarter and half year ending September 30, 2021. The date of Board Meeting for declaration of the financial results of the Company for the second quarter and half year ending September 30, 2021 will be intimated in due course. This is for your information and records.
30-09-2021
Bigul

Divis Laboratories Ltd - 532488 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Divis Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
31-08-2021
Bigul

DIVI'S LABORATORIES LTD. - 532488 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 This is to inform that the 31st Annual General Meeting (AGM) of the Company was held on August 30, 2021 at 10.00 a.m. through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM') and the business mentioned in the Notice convening the AGM dated May 29, 2021 was duly transacted. In this regard, we hereby submit the following: 1. Summary of proceedings of the 31st Annual General Meeting as Annexure - I; 2. Voting Results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure - II; 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure - III. Please note that all the resolutions set out in the Notice of 31st AGM were passed with requisite majority.
30-08-2021
Bigul

DIVI'S LABORATORIES LTD. - 532488 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 This is to inform that the 31st Annual General Meeting (AGM) of the Company was held on August 30, 2021 at 10.00 a.m. through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM') and the business mentioned in the Notice convening the AGM dated May 29, 2021 was duly transacted. In this regard, we hereby submit the following: 1. Summary of proceedings of the 31st Annual General Meeting as Annexure - I; 2. Voting Results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure - II; 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure - III. Please note that all the resolutions set out in the Notice of 31st AGM were passed with requisite majority.
30-08-2021
Bigul

DIVI'S LABORATORIES LTD. - 532488 - Chairman'S Speech And Managing Director'S Speech Delivered At The 31St Annual General Meeting Of The Company

 The Chairman's Speech and Managing Director's Speech, delivered at the 31st Annual General Meeting of the Company held today, i.e., on Monday, August 30, 2021, is enclosed herewith. This is for your information and records.
30-08-2021

Divis Labs Consolidated June 2021 Net Sales at Rs 1,960.64 crore, up 13.3% Y-o-Y

 NULL
10-08-2021
Bigul

Q1FY22 Result Announced for Divi's Laboratories Ltd.

 Consolidated Result Divi's Laboratories has earned a total income of Rs. 1997 crores for the i st quarter of the year 2021-22 on a consolidated basis, as against an income of Rs. 1748 crores for the corresponding quarter of last year. Profit before Tax (PBT) for the quarter amounted to Rs. 814 crores as against a PBT of Rs. 661 crores for the corresponding quarter of the last year. The Company earned a Profit after Tax (PAT) of Rs. 557 crores for the current quarter as against a PAT of Rs. 492 crores for the corresponding quarter of the last year. Forex gain for the current quarter amounted to Rs. 20 crores as against a gain of Rs. 5 crores during the corresponding quarter of the last year. The Company continues to have near normal operations during the quarter complying to all Covid-19 protocols. Result PDF
09-08-2021

Earnings Call for Q1FY22 of Divi's Laboratories

 Conference Call with Divi's Laboratories Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript.
07-08-2021

Divis Laboratories reports 13% jump in net profit at Rs 557 crore in Q1

 The company had reported a net profit of Rs 492 crore in the April-June quarter of the previous fiscal.
07-08-2021
Bigul

Divis Laboratories Ltd - 532488 - Outcome Of Board Meeting - Submission Of Unaudited Financial Results For The Quarter Ended June 30, 2021

 As enclosed.
07-08-2021
Next Page
Close

Let's Open Free Demat Account